Showing 2921-2930 of 4063 results for "".
- EMA’s CHMP Issues Negative Opinion of Syfovre for GA; Apellis to Seek Re-Examinationhttps://modernod.com/news/emas-chmp-issues-negative-opinion-for-syfovre-for-ga-apellis-to-seek-re-examination/2482336/The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion on the marketing authorization application (MAA) of Apellis’s intravitreal pegcetacoplan for the treatment of geographic atrophy (GA). “Although th
- Eye2Gene and Heidelberg Engineering Announce Partnership at ARVO 2024https://modernod.com/news/eye2gene-and-heidelberg-engineering-announce-partnership-at-arvo-2024/2482266/Eye2Gene, an artificial intelligence research project based at University College London and Moorfields Eye Hospital, and Heidelberg Engineering have announced a partnership aimed at advancing ophthalmic diagnostics and personalized treatment approaches. Eye2Gene, wh
- False Claims Act Complaint Filed Against Regeneron for Fraudulent Drug Pricing Reportinghttps://modernod.com/news/false-claims-act-complaint-filed-against-regeneron-for-fraudulent-drug-pricing-reporting/2482228/The US Department of Justice (DOJ) has filed a complaint under the False Claims Act (FCA) against Regeneron alleging that the company fraudulently inflated Medicare reimbursement rates for Eylea (aflibercept) by knowingly submitting false average sales price reports to CMS that excluded
- Eversight Center Awards 2024 Eye & Vision Research Grantshttps://modernod.com/news/eversight-center-awards-2024-eye-vision-research-grants/2482211/The Eversight Center for Vision and Eye Banking Research in Cleveland, Ohio, recently announced it has awarded four grants to investigators at Tufts University in Boston, Massachusetts; Wayne State University in Detroit, Michigan; and University of Michigan in Ann Arbor, Michigan, to advance prom
- GenSight Biologics Announces Initial Results from New Meta-Analyses on Visual Outcomes with Lumevoq Gene Therapy at NANOS 2024https://modernod.com/news/gensight-biologics-announces-initial-results-from-new-meta-analyses-on-visual-outcomes-with-lumevoq-gene-therapy-at-nanos-2024/2482159/GenSight Biologics announced initial results of new meta-analyses in Leber Hereditary Optic Neuropathy (LHON), which showed those treated with Lumevoq (GS010; lenadogene nolparvovec) gene therapy experienced a rate of visual recovery greater than that of idebenone-treated patients and untreated (
- American Academy of Ophthalmology Issues Warning on the Dangers of Eye Color-Changing Procedureshttps://modernod.com/news/american-academy-of-ophthalmology-issues-warning-on-the-dangers-of-eye-color-changing-procedures/2482088/The American Academy of Ophthalmology is warning the public against two eye color-changing surgeries that are trending on social media: iris implant surgery and a laser surgery that inserts pigment into the cornea. "Both of these surgeries carry serious risks for vision l
- Pixium Vision: Date Scheduled for Decision on Adoption of a Sale Planhttps://modernod.com/news/pixium-vison-date-scheduled-for-decision-on-adoption-of-a-sale-plan/2482020/Pixium Vision SA announced that following a hearing on Monday, the Paris Commercial Court will issue its decision on January 16, 2024 on the takeover offer filed on November 20, 2023 and the opening of judicial liquidation proceedings. In the event of the opening of judicial l
- Zeiss Announces New Biometry Mastery Courses in 2024https://modernod.com/news/zeiss-announces-new-biometry-mastery-courses-in-2024/2482000/Carl Zeiss Meditec is launching the Biometry Mastery Course, a program designed to enhance the skills and expertise of ophthalmic professionals. The Zeiss Biometry Mastery Course is a training initiative aimed at equipping nurses and technicians with advanced knowledge and practica
- Topcon Introduces Tempo Perimeter at AAO 2023https://modernod.com/news/topcon-introduces-tempo-perimeter-at-aao-2023/2481942/Topcon announced that it is launching the Tempo Perimeter at the American Academy of Ophthalmology (AAO) meeting in San Francisco. Tempo is designed to provides fast, accurate, and comfortable visual field testing, according to Topcon. It is 39% faster than Stan
- CooperVision to Present New Scientific Findings on Presbyopia Correction and Myopia Management at Academy ‘23https://modernod.com/news/coopervision-to-present-new-scientific-findings-on-presbyopia-correction-and-myopia-management-at-academy-23/2481873/CooperVision’s researchers and partners are scheduled to present multiple scientific posters at the